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Hematopoietic stem cells replenish all the cells of the blood throughout the lifetime of an animal. Although thousands
of stem cells reside in the bone marrow, only a few contribute to blood production at any given time. Nothing is known
about the differences between individual stem cells that dictate their particular state of activation readiness. To
examine such differences between individual stem cells, we determined the global gene expression profile of 12 single
stem cells using microarrays. We showed that at least half of the genetic expression variability between 12 single cells
profiled was due to biological variation in 44% of the genes analyzed. We also identified specific genes with high
biological variance that are candidates for influencing the state of readiness of individual hematopoietic stem cells,
and confirmed the variability of a subset of these genes using single-cell real-time PCR. Because apparent variation of
some genes is likely due to technical factors, we estimated the degree of biological versus technical variation for each
gene using identical RNA samples containing an RNA amount equivalent to that of single cells. This enabled us to
identify a large cohort of genes with low technical variability whose expression can be reliably measured on the arrays
at the single-cell level. These data have established that gene expression of individual stem cells varies widely, despite
extremely high phenotypic homogeneity. Some of this variation is in key regulators of stem cell activity, which could
account for the differential responses of particular stem cells to exogenous stimuli. The capacity to accurately
interrogate individual cells for global gene expression will facilitate a systems approach to biological processes at a
single-cell level.
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Introduction
Interest in adult stem cells has intensiﬁed since 2002, due
to renewed hope for their application to regenerative
medicine [1–8]. The adult hematopoietic stem cell (HSC), a
paradigm for understanding the mechanisms that regulate
stem cell generation and regulation, resides primarily in a
quiescent state in the bone marrow until recruited to
generate differentiated blood cells. Although an adult mouse
harbors hundreds of HSCs, only between one and ten are
thought to be active in contributing to blood production at
any time [9,10]. Nothing is known about the mechanisms that
favor activation of one stem cell over another. Presumably,
apart from micro-environmental factors, there are individual
differences in the ability of particular stem cells to respond,
based on a constellation of response genes they express at a
given time. Although several efforts have been made to study
the transcriptional proﬁle of HSC at the population level [11–
17], the ability to investigate gene expression in stem (and
other) cells at the single-cell level would be a powerful tool to
understand their biology.
In addition, the most restrictively deﬁned HSC populations
h a v en o ta l w a y sb e e np r o v e nt ob e1 0 0 %f u n c t i o n a l l y
homogeneous with regard to both differentiation and self-
renewal [18]. Although part of this inefﬁciency could be
explained by technical limitations, the successive description
of new surface markers to further enrich stem cell populations
that were previously thought to be ‘‘pure’’ [19–21] seems to
demonstrate that those are not the only factors to blame.
Furthermore, there is good evidence that highly puriﬁed HSC
populations, such as the side population (SP), can be
fractionated into sub-populations that possess distinct poten-
tial [22]. All these observations strongly argue that stem cell
populations deﬁned by current methods are heterogeneous.
Studying this heterogeneity will offer important insights
regarding stem cell physiology. Again, given the minimal
number of cells that compose highly enriched populations,
and their subsets, one needs to be able to study global genetic
expression starting with minute numbers of cells.
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proﬁling, but the methods have been applied to study a
limited number of genes [23–25] or have not been entirely
validated [26]. We have developed a strategy to amplify
transcripts from small numbers of cells that combines a
method to amplify mRNA from single cells (global single-cell
RT-PCR or GSC RT-PCR), initially described by Brady and
collaborators [27,28], and high-throughput genomic technol-
ogy, using Affymetrix microarrays [29]. Using this strategy, we
were able to accurately represent the transcriptional proﬁles
of minimal numbers of cells, including single cells. This has
allowed us to demonstrate the presence of micro-hetero-
geneity in gene expression among cells of an otherwise
phenotypically homogenous stem cell population.
Results
GSC RT-PCR Combined with Oligonucleotide Microarray
Analysis
In our experiments, murine bone marrow HSCs were
puriﬁed on the basis of their differential Hoechst dye efﬂux
ability (SP cells) [30], as well as their expression of the stem
cell antigen Sca-1 [19], and lack of the myeloid lineage marker
Gr-1. Our group has recently demonstrated that SP cells are
phenotypically Lin
 /lowSca-1
þc-kit
þThy1.1
low CD34
neg/lowFlk2
neg
and thus are, in essence, the same HSC population isolated by
other groups. Around 67% and 74% of wells sorted with
single SP or Lin
 /lowSca-1
þc-kit
þCD34
neg/low (KLS34) cells,
respectively, contained large multi-lineage colonies [31].
When we sorted KLS34 cells that had also been stained with
Hoechst, around 65% of the wells were clonogenic, indicating
that Hoechst dye is only slightly toxic to HSC. Under optimal
conditions, single cells close to the SP tip are able to engraft
long-term in approximately one third (35%) of lethally
irradiated recipients, frequencies that compare favorably
with the 20% to 33% obtained by other authors, all of which
used puriﬁcation strategies based on surface antigen ex-
pression [18,21,32]. Therefore, the HSC population we used is
highly homogeneous at a phenotypic and functional level
[22]. We will refer to the population hereafter as simply SP
cells.
One or ten SP cells were lysed in a ﬁrst strand buffer and a
limited reverse transcription was performed, generating
limited-size cDNAs that represent the 39-most few-hundred
nucleotides of most mRNA molecules in solution. These
products were then polyadenylated and ampliﬁed in a PCR
reaction primed by an oligonucleotide containing a poly-T
tract (Figure S1). The limited reverse transcription ensures
that all the ﬁrst strands have approximately the same size,
which reduces bias in the PCR ampliﬁcation potentially
caused by differences in amplicon sizes [28]. Because the
material generated in this process is dsDNA and not
biotinylated aRNA, we had to adapt the conventional
Affymetrix protocol by end-labeling the cDNA with biotiny-
lated ddATP [33,34], after determining the optimal condi-
tions for its random digestion with DNase I into fragments
averaging 50 bp. The targets thus produced were then
incubated with Murine Genome U74A version 2 microarrays
according to the standard protocol (Affymetrix, Santa Clara,
California, United States). Because the probes present on
these arrays correspond mostly to the 39 ends of the genes
represented, the fact that these targets are 39 biased should
not affect the results signiﬁcantly, provided that an appro-
priate method of analysis is chosen. Speciﬁc transcript
abundance was calculated using an implementation of the
RMA procedure. For simplicity, we will use the term ‘‘gene
expression level’’ to mean transcript abundance of a
particular gene, even though we are not exactly looking at
transcriptional rates.
Amplification and Analysis from Ten-Cell Samples
To validate the strategy with a minimum of biological
variation introduced by individual cells being in diverse states
of activity (such as different cell cycle stage), we initially
ampliﬁed transcripts from ten cells and pooled together four
of these 10-cell derived ampliﬁcations. This strategy enabled
us to run replicates of the same ampliﬁed samples and show
that the results obtained with replicates are reproducible
(Figure S2).
Even though a modiﬁcation of the GSC RT-PCR had been
shown to preserve transcriptional representation faithfully
when applied to sub-picogram quantities of puriﬁed mRNA
(diluted from a sample initially isolated from a large number
of cells) [35], our overall experimental approach had not been
tested previously. Consequently, it needed to be validated for
accuracy of relative gene expression level determination and
for power to discriminate between samples of different cell
types. In order to do this, we compared the genetic
expression proﬁle of SP cells to another small, well-deﬁned
bone marrow population, CD8 positive T lymphocytes. The
expression levels from six independent SP and three CD8
samples run in duplicate were determined using the RMA
algorithm [36,37].
Power of Discrimination
Non-supervised hierarchical clustering of samples based on
the expression levels of genes above background allowed
discrimination between all groups of samples (Figure 1A). In
other words, our ampliﬁcation and detection methods yield
genetic expression data that can be used to identify bio-
logically distinct cell populations. Statistical comparison of
the average expression level for each gene incorporating
variance information through t-statistics deﬁned three
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Synopsis
The hematopoietic stem cell (HSC) has the remarkable property of
being able to generate more stem cells or cells that are committed
to undergo differentiation into specific blood lineages. Currently,
very little is known about the specific mechanisms that underlie self-
renewal or lineage commitment. Although it is possible that some of
these mechanisms are influenced by the specific environment in
which the HSC dwells, the ultimate fate decision has to occur at the
single HSC level. The authors have developed a method that
amplifies the messages from the majority of genes that are active in
a single stem cell and combines it with large-scale genetic
expression analysis through the use of nucleic acid microarrays. A
significant fraction of these genes are found to be highly variable in
an apparently very homogeneous stem cell population, which could
be the substrate for differences in behavior of individual stem cells.
Understanding the genetic expression events at the single-cell level
would grant the ability to expand HSCs or to direct their
differentiation into specific populations, both important from a
therapeutic point of view. Furthermore, the same techniques can be
applied to other stem cell systems to investigate their physiology.groups of genes: predominant in SP (1,315 genes), predom-
inant in CD8 (1,319 genes), and not statistically different (see
Table 1 for selected genes and Table S1; all primary data from
this study are summarized in Tables S5 and S6, and are also
available for download from http://www.ncbi.nlm.nih.gov/geo,
series GSE2534). The criterion used to establish a difference
was a Student’s t-test statistic with an associated single gene p-
value , 0.05.
Accurate Prediction of Differences in Transcript
Abundance
To validate the expression levels obtained by our ampliﬁ-
cation strategy using real-time quantitative PCR (Q-PCR), we
selected 22 genes representing the full range of fold changes,
and designed PCR primer pairs for them. Relative expression
levels were then calculated using Q-PCR performed in
duplicate on two different samples of RNA. The un-ampliﬁed
RNA samples were isolated from pools of 200,000 SP cells or
900,000 CD8 cells and an amount of RNA corresponding to
approximately 2,500 cells was used in each reaction. The fold
changes computed based on RMA data were plotted against
those obtained from Q-PCR experiments (Figure 1B and
Table S2). We observed a 95% correlation coefﬁcient (p ,
0.000001) between both sources of data. This establishes that
this PCR-based ampliﬁcation method, coupled with micro-
array analysis, accurately measures expression levels to a
remarkable degree. Consistent with that reported by others
[38], the fold changes determined by microarray analysis
underestimate the true results calculated from Q-PCR
experiments, as can be appreciated by the fact that the slope
of the regression line is greater than 1.
Biological Relevance of Gene Expression Differences
In addition to being quantitatively accurate, the data
collected exhibit biological relevance. Comparison of stem
cells from a largely quiescent population with cells from an
equally resting population should emphasize cell type-speciﬁc
differences in gene expression and disregard inactive genes or
unspeciﬁc transcripts, such as those derived from house-
keeping genes. Indeed, several genes that are expected to be
preferentially expressed in CD8 cells, such as T-cell receptor
complex proteins (CD3 subunits and zeta chain, and associ-
ated kinases) and the co-receptor CD8 chains among others,
show signiﬁcantly higher expression when compared to SP
cells.Conversely,genesknown tobeassociatedwiththeSPand
HSC, including Scl/Tal-1, Ctla-2 [12,14], Mdr and Abcg2 [39], and
others, have higher levels of expression in SP cells (Table 1 and
Table S1). Therefore, our strategy is reliable for identifying
genes that are associated with particular populations.
Heterogeneity in SP Cells
We then applied these methods to investigate the degree of
heterogeneity in stem cell populations, comparing cells
isolated from different regions of the SP. Functional studies
have shown that cells appearing closer to the tip of the SP
(lower SP: LSP), thus displaying higher dye efﬂux capacity,
possess more long term hematopoietic reconstitution capacity
than those closer to its shoulder (upper SP: USP) [22]. Notably,
phenotypic analysis of surface membrane determinants in
these cells shows no major differences between these
subpopulations. Microarray analysis reveals that these sub-
populations are much more similar to each other than the SP
cells are to CD8 T cells, with only 1,082 genes being
differentially expressed. Some of these genes are listed in
Table 2, with the full table in Table S3. Analysis of the
biological function of the products of these genes shows
important ﬁndings. Several of the predominant transcripts in
the LSP correspond to poorly characterized transcription
factors. Examples include Runt related transcription factor,
Ring ﬁnger protein 1, Twisted gastrulation protein, and X-
linked Zinc ﬁnger protein. In contrast, USP cells seem to
express transcripts present in activated cells, such as E2F
transcription factor 1, Cyclin A2, Signal-induced proliferation
associated gene 1, and products associated with differentiat-
ing hematopoietic lineages, such as hemoglobin subunits,
CD14 (Myeloid Differentiation Antigen) and Ly6C. Of note,
these cells are CD45 positive, i.e. are already committed to a
hematopoietic fate, but they are still negative for surface
membrane lineage markers, such as those present in eryth-
rocytic and granulocytic lineages. Thus, it appears that these
cells may be already turning on genes related to lineage
determination, while still not displaying lineage markers.
Gene Expression Profile of Single Stem Cells
We next applied this ampliﬁcation and analysis strategy to
12 individual SP cells directly sorted into wells of a 96-well
plate. For these experiments, the SP cells from the lowest tip
that were also Sca-1
þ and Gr1
  were sorted, to ensure the
greatest possible level of functional homogeneity. When we
analyzed the expression levels of the 800 most discriminative
Figure 1. Expression Levels Determined by RMA Using GSC RT-PCR
Discriminate between Different Cell Populations and Correlate Tightly
with Those Determined by Q-PCR
(A) The figure represents a dendrogram for genes consistently above
background level in more than 50% of the samples. All the genes were
used, i.e., no prior selection for genes differentially expressed in the
different populations was done. Each 10-cell sample of the lower region
of SP cells (LA, LB, and LM), the upper region of SP cells (UN, UO, and UZ),
or CD8 T lymphocytes (XB, XC, and XD) with two replicates averaged is
represented. Unsupervised hierarchical clustering based on the Euclidean
distance between expression levels for each gene separates clearly the
three groups of samples.
(B) Twenty-two genes representing the full range of fold changes were
selected for analysis. Relative expression levels (fold changes) obtained
by RMA performed on microarrays prepared with our amplification
procedure (horizontal axis) were plotted against those calculated using
real-time Q-PCR (vertical axis). The regression equation and correlation
coefficient are shown in the graph. The 95% confidence intervals for the
regression are represented by the dashed lines.
DOI: 10.1371/journal.pgen.0020159.g001
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0.005), there was, in general, greater variability among single
cells than among 10-cell pools. However, the ampliﬁed
transcription proﬁle maintained an accurate representation
of the transcriptional proﬁle differences between distinct
populations. This can be appreciated in Figures 2A and S3,
where we can see that genes that are expressed at higher levels
in CD8 T cells (as determined by our prior analyses) tend to be
present in lower levels in each of the single cells, and vice
versa. Thus, the overall genetic expression data are not
affected and transcriptional representation is maintained.
The variability observed among single SP cell transcription
proﬁles could be due to biological differences that exist
between individual stem cells, reﬂecting true gene expression
differences between individual stem cells. Alternatively,
technical differences in the cDNA preparation, PCR ampli-
ﬁcation, or chip hybridization of each cell could account for
some or all of the variation. In order to determine exactly
what proportion of variation was due to biological versus
technical causes, we performed the same ampliﬁcation and
detection procedures in parallel on RNA from 5 single-cell-
equivalents (SCE). These SCE were made by sorting 40 SP cells
into 40 times the amount of lysis buffer and aliquoting the
cell lysate so that each ampliﬁcation and hybridization
reaction was performed with a volume and quantity of RNA
equivalent to that of a single cell. This effective pooling of the
RNA should allow us to measure variation originating in the
methodology. Single-cell ampliﬁcations contain both bio-
logical and technical variability, whereas SCE ampliﬁcations
should only represent technical variation. Using the ratio of
the SCE variances to the single cell observed variances we
determined initially a conservative estimate of the minimal
proportion of variation that can solely be attributed to
biological differences for each gene. The overall normalized
standard deviation of each gene for the SCE is indeed lower
(average 0.106) than that of the individual stem cells (0.133),
as it can be appreciated in Figure 2B. These results suggested
that at least 20% of the variation in genetic expression levels
must be exclusively due to biological ﬂuctuation or differ-
ences in the transcripts of individual stem cells. Of note,
when we compare the average expression of each gene
between individual stem cells and SCE by applying the
previously used statistical criterion (p , 0.05), only 18 genes
are found to display a fold difference   1.6. Theoretically,
since both samples represent the same population, there
should be no differences in means between them. We believe
that our ﬁndings are within the false discovery range
Table 1. Selected Genes Found to be Differentially Expressed between SP Stem Cells and CD8 T Lymphocytes Based on the
Amplification of 10 Cells
Category Probe Set Entrez Symbol Title Fold Increase p-Value
Genes with increased
expression in SP cells
161184_f_at 21846 Tie1 Tyrosine kinase receptor 1 85.87 ,0.0001
92644_s_at 17863 Myb Myeloblastosis oncogene 27.84 ,0.0001
96605_at 66058 0610011I04Rik RIKEN cDNA 0610011I04 gene 25.62 ,0.0001
96810_at 16909 Lmo2 LIM domain only 2 19.33 ,0.0001
100468_g_at 17095 Lyl1 Lymphoblastomic leukemia 19.09 ,0.0001
98324_at 15377 Foxa3 Forkhead box A3 17.73 ,0.0001
93874_s_at 16157 Il11ra1 Interleukin 11 receptor, alpha chain 1 16.61 ,0.0001
93626_at 26357 Abcg2 ATP-binding cassette, sub-family G, member 2 12.06 ,0.0001
104716_at 19659 Rbp1 Retinol binding protein 1, cellular 11.31 ,0.0001
103916_at 233806 8430420C20Rik RIKEN cDNA 8430420C20 gene 10.66 ,0.0001
97885_at 65963 1810009M01Rik RIKEN cDNA 1810009M01 gene 10.56 ,0.0001
97973_at 21349 Tal1 T-cell acute lymphocytic leukemia 1 9.64 ,0.0001
95295_s_at 14255 Flt3 FMS-like tyrosine kinase 3 7.22 ,0.0001
103518_at 13025 Ctla2b Cytotoxic T lymphocyte-associated protein 2 beta 6.54 ,0.0001
160358_at 12490 Cd34 CD34 antigen 6.21 ,0.0001
Genes with increased
expression in CD8 cells
93107_r_at 21580 Tcrb-J T-cell receptor beta, joining region 155.74 ,0.0001
93662_s_at 22637 Zap70 Zeta-chain (TCR) associated protein kinase 131.33 ,0.0001
92683_at 12500 Cd3d CD3 antigen, delta polypeptide 100.22 ,0.0001
162410_s_at 12526 Cd8b1 CD8 antigen, beta chain 1 95.21 ,0.0001
102975_at 12525 Cd8a CD8 antigen, alpha chain 25.85 ,0.0001
95373_at 12481 Cd2 CD2 antigen 23.59 ,0.0001
102971_at 12501 Cd3e CD3 antigen, epsilon polypeptide 20.15 ,0.0001
100001_at 12502 Cd3g CD3 antigen, gamma polypeptide 19.31 ,0.0001
97944_f_at 21473 Tcra T-cell receptor alpha chain 12.41 ,0.0001
102940_at 16994 Ltb Lymphotoxin B 11.58 ,0.0001
161265_f_at 16818 Lck Lymphocyte protein tyrosine kinase 9.12 ,0.0001
95363_at 16904 Gzmm Granzyme M (lymphocyte met-ase 1) 9.06 ,0.0001
93931_at 18646 Prf1 Perforin 1 (pore forming protein) 7.65 ,0.0001
102287_at 12503 Cd3z CD3 antigen, zeta polypeptide 5.93 ,0.0001
92406_at 12516 Cd7 CD7 antigen 5.63 ,0.0001
Many genes that have been associated with HSC were detected as being predominantly expressed in the SP cells. A few transcripts correspond to genes that have not been characterized
so far. Several CD8 T cell associated surface antigens as well as granule proteins were found to be expressed at higher levels in the CD8 samples amplified. See text for full comments and
Table S1 for the complete list of genes.
DOI: 10.1371/journal.pgen.0020159t001
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between a limited number of samples.
To further investigate our ﬁndings, we performed a
variance component analysis on the expression of each gene
represented in the microarrays (Figure 2C). Through this
methodology, we were able to conclude that, although most
variation in expression of the majority of the genes analyzed
is attributable to technical factors, in a signiﬁcant proportion
of genes this is not the case. Instead, true biological variability
accounts for the differences in expression levels observed
among single cells. Speciﬁcally, the percentage of genes in
which at least half of their variability is explained by
biological variation is approximately 44%. Again, this
establishes that a highly phenotypically homogeneous pop-
ulation of stem cells demonstrates real heterogeneity at the
transcriptional level.
Single-Cell Expression Analysis of Variability
In order to further clarify the ﬁnding of high variability in
expression levels of single cells, we decided to take a closer
look at the behavior of genes that have been previously
associated with stem cell biology. The RMA software provided
us with expression levels for every gene in each cell analyzed
on the array (with a theoretical distribution from zero to plus
inﬁnity), but did not establish a threshold for actual
‘‘presence’’ or ‘‘absence’’ of a transcript in a particular
sample. On the other hand, the Affymetrix microarray
analysis algorithm (MAS5) classiﬁes genes as ‘‘present’’ (P),
‘‘marginally present’’ (M), or ‘‘absent’’ (A) according to their
expression levels in a single array based on the relative
intensities of the perfect match and mismatch probes used to
detect a particular transcript. We used these deﬁnitions of
presence (P or M) and absence (A) to tentatively identify
which genes were being transcribed above background levels
at the time the GSC RT-PCR was performed.
We found that several genes previously described in
association with HSC populations, such as Sca-1, LIM domain
only 2 (Lmo2), Ctla-2a, and thrombopoietin receptor (TPO-R),
were indeed found to be present by our method in each of the
single stem cells studied. However, to our surprise, some
genes previously connected to HSC (such as Flk2, Abcg2, and
CXCR4) appeared to be expressed above background in only
a limited number of single cells. In general, the former genes
tended to have low variance between cells, but the latter
showed high variability (Figure 3A and 3B). Moreover, c-kit
had consistently an ‘‘absent’’ call across almost all of the
single-cell experiments.
To validate the differences observed between single cells,
we assessed gene expression in single HSC using individual
Table 2. Selected Genes Found to be Differentially Expressed between the Lower and the Upper SP Cells Based on the Amplification of
Ten-Cell Samples
Category Probe Set Entrez Symbol Title Fold Increase p-Value
Genes with increased
expression in the LSP
100014_at 24086 Tlk2 Tousled-like kinase 2 (Arabidopsis) 19.84 ,0.0001
93851_at 56187 Rabggta Rab geranylgeranyl transferase, a subunit 12.3 ,0.0001
103242_at 11765 Ap1g1 Adaptor protein complex AP-1, gamma 1 subunit 11.79 ,0.0001
96836_r_at 22666 Zfp161 Zinc finger protein 161 11.39 ,0.0001
95451_at 72722 2810405J04Rik RIKEN cDNA 2810405J04 gene 9.51 0.003
99475_at 216233 Socs2 Suppressor of cytokine signaling 2 9.38 ,0.0001
92195_at 12611 Cebpg CCAAT/enhancer binding protein (C/EBP), gamma 9.19 ,0.0001
160973_at 224171 C330027C09Rik RIKEN cDNA C330027C09 gene 8.75 ,0.0001
95033_at 104263 Jmjd1a Jumonji domain containing 1A 7.73 ,0.0001
97293_at 236732 Rbm10 RNA binding motif protein 10 7.36 ,0.0001
104202_at 216131 Tmem1 Transmembrane protein 1 7.06 ,0.0001
95433_at 71990 Ddx54 DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 7.01 ,0.0001
94526_at 52637 D10Ertd214e DNA segment, Chr 10, ERATO Doi 214, expressed 5.39 ,0.0001
93528_s_at 16601 Klf9 Kruppel-like factor 9 5.39 ,0.0001
160846_at 59126 Nek6 NIMA (never in mitosis gene a)-related expressed kinase 6 4.17 ,0.0001
Genes with increased
expression in the USP
96337_at 14724 Gp1bb Glycoprotein Ib, beta polypeptide 20.39 ,0.0001
103797_at 12545 Cdc7 Cell division cycle 7 (S. cerevisiae) 11.63 ,0.0001
161092_at 22247 Umps Uridine monophosphate synthetase 8.17 ,0.0001
104704_at 12727 Clcn4–2 Chloride channel 4–2 7.89 0.001
102905_at 12363 Casp11 Caspase 11, apoptosis-related cysteine peptidase 7.21 ,0.0001
104138_at 100163 Pafah2 Platelet-activating factor acetylhydrolase 2 6.32 ,0.0001
94781_at 15122 Hba-a1 Hemoglobin alpha, adult chain 1 5.28 0.001
100125_at 18813 Pa2g4 Proliferation-associated 2G4 4.99 ,0.0001
99186_at 12428 Ccna2 Cyclin A2 4.41 ,0.0001
103499_at 22371 Vwf Von Willebrand factor homolog 3.58 ,0.0001
102963_at 13555 E2f1 E2F transcription factor 1 3.41 0.001
98088_at 12475 Cd14 CD14 antigen 3.34 0.001
100467_at 17095 Lyl1 Lymphoblastomic leukemia 3.16 0.006
103534_at 15130 Hbb-b2 Hemoglobin, beta adult minor chain 2.68 0.038
101869_s_at 15127 Hbb Hemoglobin beta chain complex 2.57 0.045
Several of the predominant transcripts in the LSP correspond to scantily characterized transcription factors. In contrast, USP cells seem to express transcripts present in activated cells and
products associated with differentiating hematopoietic lineages. See text for full comments and Table S3 for the complete list of genes.
DOI: 10.1371/journal.pgen.0020159t002
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as high and low expression were chosen. Gene expression
patterns of genes considered to be ‘‘present’’ (i.e., genes with
P call) or ‘‘marginally present’’ (i.e., genes with M call) by
microarray analysis showed similar patterns of expression by
Q-PCR (Table 3). For example, as predicted by our micro-
array experiments, Ctla-2a and Lmo2 were both found to be
expressed on all 12 single-cell microarrays and in all single-
cell Q-PCR experiments. Moreover, Lyl1 and Scl were found
in approximately half of the single-cell Q-PCR ampliﬁcations,
similar to the rate identiﬁed by our GSC RT-PCR combined
with microarray strategy. In contrast, c-kit, which was
considered to be ‘‘absent’’ on 11 single cell microarrays and
‘‘marginally present’’ on one of them, was shown to be
expressed in 53% of HSC tested by real-time RT-PCR,
indicating that lack of detection on a microarray with our
method does not necessarily represent true absence of mRNA
expression. As expected, Q-PCR is as, or more sensitive, than
microarray detection. A few instances in which Q-PCR seems
to be less sensitive, such as for Bmp1 and Csnk2a2, could be
related to non-speciﬁc cross-hybridization during microarray
incubation.
As discussed above, variation in gene expression levels in
our study can reﬂect either true biological variability, or
technical variability. Our variance component analysis and
our Q-PCR results suggest that a signiﬁcant part of the
Figure 2. Genetic Representation of Single-Cell Amplifications
(A) The transcriptional profiles obtained for individual SP stem cells maintain an accurate representation of the overall genetic differences between
populations. The genes that are statistically most different between SP cells and CD8 T lymphocytes (p , 0.005), as determined by the 10-cell
amplification experiments, are displayed in the heat map. Expression levels were normalized to 1 (white). Red genes are over-expressed and blue genes
under-expressed in that sample. HSA through HSL are the results of the amplification of individual single SP cells mRNA. HWA is an average obtained for
SCE amplifications (see text for explanation). XB1 through XD1 are the results for 10 CD8 T-cell amplifications. Genes that are expressed at higher levels
in CD8 cells are generally expressed at lower levels in the individual SP cells and vice versa: the individual SP cell amplifications display the same overall
transcriptional profile as the amplifications performed in a larger number of cells; the same applies to the SCE amplifications (for individual SCE profiles,
see Figure S3).
(B) The variance of single-cell amplifications (SC) is higher than SCE. The figure shows the standard deviation (SD) of the genes from SC and SCE
experiments. The box plot shows the inter-quartile range and median of the SD values. For visual clarity, outlier values are not shown. The median
standard deviation is higher in the single cell experiments, suggesting clear evidence for biological variation among the single cells.
(C) Variance component analysis shows that a significant proportion of genes has a large component of biological variance. The graph represents the
density of genes plotted against the ratio between the biological variance estimate and the total variance (the sum of the biological and technical
variances). This ratio varies from 0 (all the variability in gene expression levels across single cells is attributable solely to technical variability) to 1 (all the
variability is due entirely to biological variability). For the majority of genes, there is little or no biological variance. However, there is a sizeable share of
genes with expression levels that exhibit extreme biological variance. The area under the curve indicates that the percentage of genes in which at least
half of their variability is explained by biological variation is approximately 44%.
DOI: 10.1371/journal.pgen.0020159.g002
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which genes are reliably detected and biologically informa-
tive, several points need to be considered. Technical
limitations can be due to poor ampliﬁcation of some genes,
or poor detection by non-optimal probes on the array; these
genes will likely exhibit low expression levels with our
technique even in the single-cell equivalents, and will have a
small component of biological variability in the variance
analysis. On the other hand, there are genes that display low
variance across each of the single-cell-equivalent experi-
ments, but still show high variability among single cells. In
other words, these genes are detected at a similar level on
identical mRNA samples (and consistently expressed on
average in the stem cell population as a whole), but that they
still show great variability between individual stem cells,
which is detectable by our method and conﬁrmed by Q-PCR.
This second group of genes displays a large component of
biological variance and is therefore the likely source of the
biological variation observed in our data, making them
potentially responsible for the functional variability of HSC
(Figure 4 and Table S4).
To further characterize the biological differences between
high and low biological variance genes, we performed a Gene
Ontology (GO) analysis on the list of genes representing those
two groups. For the purpose of the GO analysis, we deﬁned
high biological variance (HBV) genes as those having an
estimated proportion of biological variance greater than 95%
and with a P call in at least a third of the single cell arrays (467
probe sets); low biological variance (LBV) as those with less
than 5% of biological variance and P calls in all single cell
arrays (361 probe sets). We selected these cutoffs based on a
density estimate of the proportion of biological variance
across all genes as shown in Figure 2C. This density estimate
shows clear bi-modality, and the 5% and 95% cutoffs are the
approximate modes of the two peaks in the density estimate.
Additionally, these two well-separated cutoffs seemed appro-
priate to determine two widely disparate variance based
classes.
The GO categories signiﬁcantly associated with each gene
list deﬁned GO signatures for HBV and LBV genes. Examples
Figure 3. Expression Levels of Genes Previously Associated with HSC
Genetic Profile
Each single SP cell amplification experiment is represented by a different
column (A–L). Genes given a P call by MAS5 are represented in red.
Otherwise, they are shown in blue. The white numbers in the boxes
represent the logged (base 2) gene expression levels calculated by RMA.
The SCE column summarizes the number of P calls across five single-cell-
equivalent (see text for explanation) amplification reactions.
(A) Genes consistently present in all single cell amplifications performed
using GSC RT-PCR followed by oligonucleotide array analysis.
(B) Genes detected less frequently than expected. This can potentially be
due to technical limitations or true biological variability among cells.
DOI: 10.1371/journal.pgen.0020159.g003
Table 3. Q-PCR Validation of Single-Cell Microarray Data
Gene Symbol Microarray PþM Call Q-PCR Positivity
Ctla2a 100% (12/12) 100% (36/36)
Lmo2 100% (12/12) 100% (31/31)
Bsg 100% (12/12) 67% (14/21)
Lyl1 58% (7/12) 50% (8/16)
Bmp1 58% (7/12) 20% (2/10)
Ninj1 50% (6/12) 55% (11/20)
Degs1 50% (6/12) 50% (5/10)
Tal1/Scl 50% (6/12) 41% (58/140)
Nr4a2 42% (5/12) 80% (8/10)
Rbx1 42% (5/12) 36% (4/11)
Csnk2a2 42% (5/12) 9% (1/11)
Jun 33% (4/12) 56% (5/9)
Evi2 33% (4/12) 38% (3/8)
Phb 33% (4/12) 36% (4/11)
Vdr 33% (4/12) 50% (5/10)
Esr1 8% (1/12) 6% (1/16)
c-Kit 8% (1/12) 53% (18/34)
Cd2 0% (0/12) 0% (0/12)
Cd48 0% (0/12) 0% (0/12)
Pgr 0% (0/12) 0% (0/12)
The table displays microarray and Q-PCR results assaying the expression of the indicated
genes in single HSC. Data in the microarray column indicate the percentage of single-cell
microarrays in which the designated gene was called ‘‘present’’ or ‘‘marginal’’ by the
MAS5 algorithm. The Q-PCR column lists the percentage of single-cell Q-PCR reactions in
which the designated gene had a detectable signal within 60 cycles of amplification,
which was our criterion for positivity. The numbers in parentheses represent the fraction
of cells with a positive signal versus the total number of cells tested.
DOI: 10.1371/journal.pgen.0020159t003
Figure 4. Selected Genes Consistently Expressed in SCE (Low Variance of
Expression Levels), but Displaying High or Low Variability in Single SP
Cells
Genes with low variance in the SCE are likely to be detected accurately
by our amplification procedure, since a fraction equivalent to one cell of
the same pool of mRNA gives a consistent result across experiments: any
variation detected in single cells should therefore reflect true differences
in levels of gene expression. Some of these genes have low variation in
single cells (B), while others (A) display different levels in distinct stem
cells. The latter are likely to be responsible for heterogeneity in behavior
of individual HSC (see Figure 3 for an explanation of the colors and
numbers used).
DOI: 10.1371/journal.pgen.0020159.g004
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are represented in Table 4. The full GO analysis tables are
available as Tables S7 and S8.
Salient features in the LBV group include an overrepre-
sentation of genes involved in intermediate metabolism in
the LBV signature. Furthermore, genes related to reactive
oxygen species metabolism are also part of the LBV signature.
This is of particular relevance since recent reports have
highlighted the importance of these pathways in the self-
renewal and control of life span of HSC [40,41]. Although the
HBV signature also includes some metabolic genes, some
categories appear to be speciﬁc to HBV, including genes
related to DNA repair and replication, nuclear import,
response to DNA damage stimulus and translational initia-
tion (Table 4). Furthermore, a group of genes whose function
has been traditionally attributed to osteoblast differentiation
is signiﬁcantly associated with HBV.
Examples of genes in the DNA repair and response to DNA
damage categories include Apex1 (apurinic/apyrimidinic
endonuclease 1), Ercc2 (excision repair cross-complementing
repair deﬁciency, group 2), Lig1 (ligase I, DNA, ATP-depend-
ent), and Pttg1 (pituitary tumor-transforming 1). Lack of
Apex1 has been involved in increased spontaneous muta-
genesis in somatic and germ cells [42]. Ercc2 has been
previously described in the context of premature aging and
decreased life span associated with increased sensitivity to
oxidative damage [43]. Absence of Pttg1 causes a variety of cell
growth abnormalities [44]. Runx2 (runt related transcription
factor 2) and Cbfb (core binding factor beta) belong to the
‘‘osteoblast differentiation category’’, but they may actually
Table 4. Sample of GO Classes with Examples of Corresponding Genes Found in GO Signature Tables for High and Low Biological
Variance Component Genes
Category GO Classification
(Genes in Signature/
Genes in Class)
GO ID p-Value Probe Set Symbol Gene Entrez Prop
Bio
Sample of GO classes
and examples of genes
with high proportion of
biological variance in
single SP cells
DNA repair 0006281 0.0369 93559_at Apex1 Apurinic/apyrimidinic endonuclease 1 11792 0.998
(9/91) 92278_at Ercc2 Excision repair cross-complementing
repair deficiency, group 2
13871 0.980
101026_at Pttg1 Pituitary tumor-transforming 1 30939 0.961
DNA replication 0006260 0.0451 92551_at Lig1 Ligase I, DNA, ATP-dependent 16881 0.974
(8/80) 93356_at Mcm7 Minichromosome maintenance
deficient 7 (S. Cerevisiae)
17220 0.997
94855_at Phb Prohibitin 18673 0.994
Nuclear import 0051170 0.0284 95034_f_at Ipo4 Importin 4 75751 0.984
(5/35) 102476_f_at Xpo7 Exportin 7 65246 0.964
94228_at Xpo1 Exportin 1, CRM1 homolog (yeast) 103573 0.955
Osteoblast differentiation 0001649 0.0298 92676_at Runx2 Runt related transcription factor 2 12393 0.987
(3/14) 93547_at Cbfb Core binding factor beta 12400 0.970
Translational initiation 0006413 0.0484 93859_at Mtif2 Mitochondrial translational initiation factor 2 76784 0.999
(4/28) 95462_at Bzw2 Basic leucine zipper and W2 domains 2 66912 0.997
160365_at Eif2s2 Eukaryotic translation initiation factor 2,
subunit 2 (beta)
67204 0.986
Sample of GO classes
and examples of genes
with low proportion of
biological variance in
single SP cells
Carbohydrate biosynthesis 0016051 0.0151 98593_at Cmas Cytidine monophospho-N-acetylneuraminic
acid synthetase
12764 0.006
(5/40) 100574_f_at Gpi1 Glucose phosphate isomerase 1 14751 0.000
103002_at B4galt1 UDP-Gal:bGlcNAc b1,4-galactosyltransferase,
polypeptide 1
14595 0.000
Reactive oxygen species
metabolism
0006800 0.0353 102326_at Ncf2 Neutrophil cytosolic factor 2 17970 0.000
(4/34) 162077_f_at Scd2 Stearoyl-Coenzyme A desaturase 2 20250 0.000
95356_at Apoe Apolipoprotein E 11816 0.000
Protein biosynthesis 0006412 0.0000 100213_f_at Rpl41 Ribosomal protein L41 67945 0.000
(40/329) 100686_at Rps2 Ribosomal protein S2 16898 0.000
100694_at Rplp1 Ribosomal protein, large, P1 56040 0.000
100711_at Rpl10a Ribosomal protein L10A 19896 0.000
Protein catabolism 0030163 0.0134 100733_at Psma2 Proteasome (prosome, macropain)
subunit, alpha type 2
19166 0.000
(9/103) 101042_f_at Pep4 Peptidase 4 18624 0.000
92660_f_at Ube2e1 Ubiquitin-conjugating enzyme E2E 1,
UBC4/5 homolog (yeast)
22194 0.000
RNA metabolism 0016070 0.0068 101590_at Lamp2 Lysosomal membrane glycoprotein 2 16784 0.000
(16/219) 160182_at Sfrs6 Splicing factor, arginine/serine-rich 6 67996 0.000
160429_at Nxt1 NTF2-related export protein 1 56488 0.000
160555_r_at Snrpb Small nuclear ribonucleoprotein B 20638 0.000
Each class comprises several more genes than those listed as examples. The LBV list contains a disproportionate amount of genes related to intermediate metabolism. Although metabolic
genes are also represented in the HBV list, some categories are specific to it, including DNA repair and response to DNA damage stimulus, nuclear import, and translation initiation. The p-
value in the table is a measure of the strength of association of a particular category with a specific gene list (see Materials and Methods). Prop bio is the estimated proportion of biological
variance for that particular gene. See text for full comments and Tables S7 and S8 for the complete list of high and low biological variance component GO signatures and respective genes.
DOI: 10.1371/journal.pgen.0020159t004
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proteins have been shown to be required for normal
maturation of hematopoietic cells as well as establishment
of deﬁnitive hematopoiesis [45,46], and both have been
associated with leukemogenesis [47]. Overall, it seems that
whereas LBV is associated with a housekeeping function,
HBV likely translates different states of readiness, switching
mechanisms from a quiescent to a proliferative state or even
control of early commitment steps.
In order to exclude any bias introduced in our results by
the different localization of the probes along each gene, we
also examined the extent to which probe location within
transcripts was associated with the variance components. We
found no difference in the median relative probe position
between the groups of probe sets corresponding to HBV and
LBV genes (Figure S4) demonstrating that HBV do not result
from their probes being less 39 biased than LBV. Finally, we
took a closer look at the relationship between the intensity of
the probes and the estimated proportion of biological
variance. Because of their nature, HBV genes are likely to
have on average lower expression levels: being variable means
that sometimes there is no transcript present and this will
bring the average expression levels lower. Therefore, better
than comparing the distribution of average intensity of genes
between HBV and LBV groups is to look at the distribution of
the maximum intensity for each gene (since the theoretical
maximal level of expression will never be lower than this
value). When we do this, we can see that while it is true that
HBV genes tend to have maximal expression levels slightly
lower than those with LBV, both HBV and LBV gene lists
have signiﬁcant proportions of low expression level genes
(Figure S5). This argues again that HBV does not result solely
from differences in probe intensity (which would be
disregarded by the SCE experiments). Instead, it suggests
that HBV genes have more labile transcriptional levels, as
opposed to highly expressed LBV genes.
Discussion
Here, we have demonstrated that gene expression proﬁles
of minimal numbers of cells, from a single cell to as few as ten
cells, can be obtained using microarray technology. The
method is both remarkably reproducible and accurate,
generating proﬁles that can be used to cluster cell types with
ﬁdelity and to predict gene expression differences that can be
readily validated using quantitative real-time PCR (Figure
1B). This methodology will be important for further inves-
tigating differences between these and other stem cell types,
and understanding the role that micro-heterogeneity has in
dictating biological function.
In contrast to previous efforts, we have studied the genetic
expression of individual stem cells, instead of a population of
stemcells[11–17].A fewauthors havepreviously addressedthe
transcriptional proﬁle of single cells of developing pancreas
[24], metastatic foci [23], or adult hippocampus [25], but these
studies have used platforms containing a limited number of
genes. A previous publication has examined single olfactory
neurons [26], which are very large cells containing substantial
amounts of mRNA, but the expression levels of individual
genes was not validated. We have demonstrated that the
average relative expression levels determined by our method
are accurate, examined the expression of tens of thousands of
genes simultaneously and studied cells that have minimal
cytoplasm and thus scant mRNA. Furthermore, by analyzing
the transcriptional proﬁle of stem cell equivalents, we were
able to identify which genes are reliably measured using our
method, which is unique to this study.
Similar to others, we have been unable to identify a group
of genes that is speciﬁc for (i.e. only expressed in) HSCs.
However, our work establishes that genetic expression
differences within puriﬁed stem cell populations exist, which
is critical when considering stem cell function. Our observa-
tions substantiate existing evidence suggesting variability in
patterns of gene expression between individual cells in
hematopoietic stem and progenitor cells and that have
established the notion of multi-lineage gene priming [48–
50]. The ﬁndings in these papers, which point to promiscuity
in the expression of lineage-speciﬁc genes in early progen-
itors, support our results showing (possibly combined) early
expression of myeloid and erythroid markers in the upper SP
(which is lineage negative, by surface markers). However, it
should be noted that the main focus of these above-
referenced papers is that HSC or progenitors simultaneously
express genes from different lineage-committed cells. The
meaning of this ﬁnding and the potential reasons why this
had not been seen previously by other investigators are
discussed in the papers. Although some variability in
expression of individual cells was noted, this was not the
focus of the studies. Our work is also unique in that we have
studied genetic expression differences at a much larger scale
than single-cell RT-PCR for a limited number of genes.
When others have analyzed the genetic expression proﬁles
of single cells from relatively homogeneous populations
[24,51], while some of the transcripts studied were regularly
detected in every cell, they also found consistent variation in
expression levels of other genes. By studying the ampliﬁcation
of single cell equivalents, we have established that this cannot
exclusively be ascribed to technical limitations. The use of SCE
is superior to other possible strategies, such as studying a
putative more homogenous population or establishing a
threshold of detection for speciﬁc genes by spiking a known
number of RNA molecules in our samples. On one hand, a
common pool of RNA obtained by aliquoting a mixture of a
few cells is more homogenous than even a cell line. On the
other hand, a complex mixture of RNA will have ampliﬁcation
kinetics different from an isolated single molecule of RNA and
any particular gene present in a complex mixture of RNA will
have its own ampliﬁcation kinetics. The comparison between
single cells and SCE should tell us not only whether we are
looking at real biological variation, but also what the inherent
noise of the measurement is.
Our single-cell data corroborate previous observations that
suggest that transcriptional activity is ‘‘quantal’’ and that,
most likely, genes that are know to be active in a certain
population may not necessarily be constantly transcribed at
the same levels in every single cell [52–55]. Genetic expression
ﬂuctuation is indeed thought to occur in single cells from
otherwise homogeneous populations and could constitute the
basis for differences in stem cell fate and behavior. The
differences that we observed between individual SP cells may
be inherently stochastic or caused by micro-environmental
differences in the stem cell niche, and may also dictate their
differential response to activating stimuli. In turn, these may
translate into diversity in the level of readiness of each stem
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distinct lineages.
In any case, one striking observation is that some genes
exhibit very low variance between the single cells, while other
genes exhibit high biological variance. The GO analysis
indicates that the LBV genes primarily serve a house-keeping
function, while the HBV group includes genes which seem to
affect the state of readiness. This is likely related to the still
poorly understood question of why only a few stem cells are
activated at any given time. Some of the HBV genes identiﬁed
here may dictate which cells are utilized ﬁrst.
Although it is evident that we can detect biological
differences, because of technical limitations, the expression
of some genes will simply not be measurable using this
technique. As previously observed in other studies of tran-
scriptional proﬁling, some probe sets present on the
Affymetrix microarrays tend not to be informative. These
sets likely cross-react with repetitive sequences, recognize
similar sequences in unrelated transcriptionally active genes
or simply have poor hybridization kinetics. In addition, some
genes are recognized on the array by multiple distinct probe
sets, which in some cases give very different results. Because
our method relies on the ampliﬁcation of the 39-most
portions of transcripts, the minority of probe sets that are
less 39-biased (or well-distributed throughout the gene) may
not detect the expression of some genes.
Expressionofc-kit,negativeonthearraybutvariablypositive
in the Q-PCR, illustrates this point. However, c-kit also
illustrates potential discrepancies between protein and mRNA
expression,andespeciallybetweenproteinlevels andtranscript
levels. We know from many other experiments that all SP cells
puriﬁed as done here express abundant c-kit protein on their
surface. Yet, that does not necessarily mean that this gene is
being transcribed at high levels in every HSC. It is also possible
that the low level of mRNA reﬂects a post-transcriptional
regulation of c-kit, such as rapid degradation, that merits
further study. One needs to keep in mind that gene expression
levels calculated by microarray analysis are in fact measure-
mentsoflevelsofspeciﬁctranscripts,whichinturndependboth
ongene expression activity and competing mRNA degradation.
In brief, some genes in the array will not be informative
using our strategy. However, a considerable amount of them
are reliably detected and we feel that, for the purposes of our
experimental plan, the most informative candidates are those
that have a consistent expression above background in the
stem-cell equivalent experiments but variable detection
between individual SP cells, even though this deﬁnition may
overlook some important genes, such as Bmi1, which have
moderate expression levels. In any case, based on our data, a
signiﬁcant proportion of genes on the array (almost half of
those with a ‘‘present’’ call in at least a single cell) should be
informative. Future studies of the role of genes differentially
expressed among single stem cells will bring important
insight regarding their physiology. Further reﬁnements in
microarray technology, PCR technique, ampliﬁcation meth-
ods [56], and oligonucleotide chemistry will undoubtedly
increase the detection accuracy by the GSC RT-PCR
combined with oligonucleotide microarray strategy.
Our method will also be of use to derive gene expression
proﬁles from limited number of cells that can be obtained
using laser capture micro-dissection from tissue sections,
enabling the deﬁnition of pre-disease gene proﬁles. Likewise,
this methodology may be applicable to rare cell types that can
only be identiﬁed currently by morphology and location, such
as intestinal [57] stem cells and melanocytes [58]. Finally,
single-cell expression proﬁling may be able to uncover
genetic pathways in highly characterized biological systems
such as Caenorhabditis elegans, where single genes are known to
direct individual cell fate, but the down-stream consequences
of master-gene expression are not fully understood.
Materials and Methods
Animals. C57Bl/6 CD45.1 mice were used at 7–9 wk of age. Mice
were bred and maintained on acidiﬁed water in the animal care
facility at Baylor College of Medicine.
Cell sorting. For single or ten-cell experiments, whole bonemarrow
(WBM) was collected from the femora and tibiae of one mouse as
previously described. For RNA isolation to use in Q-PCR, WBM was
obtained from ﬁve mice and enriched for Sca-1 positive or CD3-
positive cells using magnetic beads (autoMACS; Miltenyi Biotec,
Sunnyvale, California, United States) conjugated with anti-biotin
antibodies after incubation of the cells with biotinylated antibodies
against the former molecules. The SP samples were initially incubated
with Hoechst 33342 (Sigma, St. Louis, Missouri, United States) as
previously described and stained with PE-conjugated anti-Sca-1
antibody (or PE-conjugated streptavidin) and FITC-conjugated anti-
Gr-1 (Ly6G)/Ly6C antibody and sorted for cells positive for Sca-1 and
negative for Gr-1/Ly6C in the SP region. The LSP was deﬁned as the
lower third of the SP region and the USP as the upper third of the SP
region. The SP region was deﬁned conservatively and did not include
the upper shoulder of the tail. There was no overlap between USP and
LSP.TheCD8þTcellsampleswerestainedwithFITC-conjugatedanti-
CD3 antibody (or FITC-conjugated streptavidin) and PE-conjugated
anti-CD8antibody and sorted for doublepositives(all antibodiesfrom
BD Pharmingen, San Diego, California, United States).
Global single or minimal number cell RT-PCR. We sorted single-
cell or ten-cell samples using a MoFlo (Cytomation, Fort Collins,
Colorado, United States) into individual wells of a 96-well PCR plate
containing 4 ll of lysis buffer. For 100 ll of lysis buffer, we combined
76 ll of RNase free water, 20 ll of ﬁrst strand buffer (20 mM Tris-HCl
[pH 7.5], 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.01% v/v NP-40,
and 50% v/v glycerol), 1 ll of Prime RNase inhibitor (Brinkmann,
Westbury, New York, United States), 1 ll of RNase Guard (Promega,
Madison, Wisconsin, United States), 0.5 ll of NP-40, and 2 ll of a fresh
1/24 dilution of stock primer mix. The stock primer mix was prepared
adding 1 ll of 100 mM dATP, 1 ll of 100 mM dCTP, 1 ll of 100 mM
dGTP, 1 ll of 100 mM dTTP, and 2 ll of 500 lg/ml oligo-dT12–18
(Invitrogen, Carlsbad, California, United States) to 2 ll of RNase free
water (Promega).
Following sorting, cells were incubated 1 min at 65 8C (to lyse the
cytoplasmic membrane—the nuclear envelope remains intact—and
denature the mRNA), 2 min at 25 8C (to allow the oligo-dT to anneal
to the poly-A tails of the mRNA), and chilled on ice. Next, we added
0.5 ll of a 1:1 mix of M-MLV (200 U/ll) and AMV (2.5 U/ll) reverse
transcriptases and we incubated the plate at 37 8C for 15 min and 65
8C for 10 min (to inactivate the enzymes).
After the RT, we added 4.5 ll of tailing buffer and 0.4 ll (25 U/ll) of
terminal deoxynucleotidyl transferase (TdT) (Roche, Nutley, New
Jersey, United States) and let this polyadenylation reaction run for 15
min at 37 8C, followed by an inactivation step of 10 min at 65 8C. The
tailing buffer was made by mixing 400 llo f53TdT buffer (500 mM
potassium cacodylate [pH 7.2], 10 mM CoCl2, and 1 mM DTT)
(Invitrogen)with15llof100mMdATPand585llofRNase-freewater.
Next, we added 90 ll of PCR mix to the resulting products and
performed the following PCR program: 25 cycles of 2-min denatura-
tion at 94 8C, 2-min annealing at 42 8C, and 6-min (extending 10 s
each cycle) extension at 72 8C. This was followed by, after adding
extra 1 ll( 5U / ll) AmpliTaq (Roche), the same PCR program, without
prolonging the extension time each cycle. For each PCR reaction, we
mixed 53.5 ll of water, 10 llo f1 0 3 PCR buffer II (100 mM Tris-HCl
[pH 8.3] and 500 mM KCl), 10 ll of 25 mM MgCl2,9ll of 200 lM AL-1
primer, 4 ll of 100 mM dNTP, 1 ll of 5% v/v Triton X-100, 0.5 llo f2 0
mg/ml bovine serum albumin, and 2 ll of AmpliTaq (5 U/ll). After the
PCR, we ran 5 ll of each ampliﬁed product in a 1.5% agarose gel. If
the ampliﬁcation is successful, you should see a smear extending from
around 300 bp to 1,200 bp (around 1 lg of DNA). However,
frequently you can also see a smear in your negative (no cell) controls.
This has been described previously [28] and is thought to result from
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successfully ampliﬁed cells, we prepared a Southern blot and probed
it for a housekeeping gene (GAPDH). See Protocol S1 for a comment
on the GSC RT-PCR method.
Target fragmentation. The remaining poly-A cDNA was puriﬁed in
a PCR cleanup column (Qiagen, Valencia, California, United States)
and eluted in 50 ll of 10 mM Tris-HCl [pH 8.5]. We then used a Speed
Vac machine (Jouan, Winchester, Virginia, United States) or Micro-
con-30ﬁlterdevices(Millipore,Billerica,Massachusetts,UnitedStates)
to concentrate 25 lg of poly-A cDNA to 67.5 ll and added 14.2 llo f
buffer mix. Buffer mix was prepared by combining 10.5 ll of One-
Phor-All (Amersham, Piscataway, New Jersey, United States) buffer
(100 mM Tris-acetate [pH 7.5], 100 mM magnesium acetate and 500
mM potassium acetate) to 6.6 ll of 25 mM CoCl2. We next added 0.5 U
of DNaseI (1 U/ll) (Invitrogen) and 9.5 ll ofits respective 13buffer (20
mM Tris-HCl [pH 8.4], 2 mM MgCl2, 50 mM KCl) and incubated the
reaction for 3 min at 37 8C, followed immediately by placement in a
boiling water bath for 15 min [33,34]. Adequate fragmentation of the
cDNA should generate segments averaging 50 bp. The optimal
concentration of DNase I and digestion time have been titrated for
our reaction, by running a digested sample aliquot on a denaturing
10% PAGE together with an appropriate molecular weight marker.
Target labeling. In order to end-label the cDNA fragments with
biotin, we next added 3.12 ll of 1 mM N
6-biotinylated ddATP
(PerkinElmer, Boston, Massachusetts, United States) and 4.25 llo f
TdT (15 U/ll) (Invitrogen) and incubated the reaction at 37 8C for 2 h
[33,34].
Microarray incubation. The biotin-labeled fragments were used
directly as targets for GeneChip Murine Genome U74A version 2
microarrays (Affymetrix, Santa Clara, California, United States)
according to the Affymetrix standard protocol, but scaling down
reactions to a ﬁnal hybridization mixture volume of 250 ll. After
hybridizationwith200llofthissolution(equivalentto20lgofcDNA),
the arrays were incubated according to the Affymetrix protocol
(antibody ampliﬁed) with phycoerythrin-conjugated streptavidin.
Microarray analysis. The raw intensity data for each probe were
collected with Microarray Suite version 5.0 software, MAS5, from
Affymetrix (http://www.affymetrix.com). Expression levels for each of
the genes represented in the array was computed in the R statistical
programming environment using the Bioconductor implementation
of the RMA method (http://www.bioconductor.org). The primary data
used in our work are compiled in Table S5. Analysis to compute linear
model and ANOVA results was also performed in R using the limma
package and using the mixed model methods in the limma package to
account for technical replication. As well, the limma based empirical
Bayes methods were used to enhance the single gene T-statistics. A
gene was considered to be differentially expressed between groups if a
Student’s t-test statistic had an associated p , 0.05. In generating
tables of differentially expressed genes, we used unadjusted p-values,
but we provide both the unadjusted and the adjusted p-values
(calculated with the Benjamini-Hochberg linear step up procedure)
in Tables S1 and S3. The use of the t statistic is more adequate for our
type of experiments than the application of an absolute threshold for
fold change. On the one hand, genes that have small fold changes but
consistent levels (i.e., low variance) within different groups of samples,
will be tagged as differentially expressed. On the other hand, genes
that display high variability, either reﬂecting true biological ﬂuctua-
tions or limitations of the ampliﬁcation method, will not be
considered to be different between groups because their variances
will be too high. Consequently, several false discoveries of genetic
expression differences between groups will be avoided.
Q-PCR validation for population expression levels. We designed
primers for a total of 22 randomly selected genes: seven whose
expression levels were signiﬁcantly higher in T cells, eight in SP cells,
and seven not statistically different (Table S2). We isolated total RNA
from a minimum of 200,000 SP or CD8 cells, pooled from different
sorting experiments, using the RNeasy kit (Ambion, Austin, Texas,
United States). The RNA was digested with DNAse I (Invitrogen) and
resuspended in RNase free water (Promega) at a ﬁnal concentration
corresponding to 20,000 cells per ll. Each 10 ll of RNA solution was
incubated with 1 ll of 500 lg/ml oligo-dT12–18 (Invitrogen) and 1 llo f
10 mM dNTP (Invitrogen) at 65 8C for 5 min. We then added 4 llo f
ﬁrst strand buffer (Invitrogen), 2 ll of 1 M DTT (Invitrogen) and 1 ll
of RNAse out (Invitrogen) and kept the mixture at 42 8C for 2 min.
Finally, we performed a reverse transcription reaction by adding 1 ll
of SuperScript (Invitrogen). No-RT controls were done in parallel for
each initial RNA sample and used to assess contamination with
undigested DNA. The cDNA obtained had a ﬁnal concentration
corresponding to 10,000 cells per ll.
Each Q-PCR reaction was performed by mixing 5 llo f1 0 3 PCR
buffer with SYBR Green (PerkinElmer), 6 ll of 25 mM MgCl2,4llo f
12.5 mM dNTP, 0.25 ll of AmpliTaq (5 U/ll) (PerkinElmer), 3 llo f5
mM forward primer, 3 ll of 5 mM reverse primer, 0.25 ll of cDNA
template (equivalent to approximately 2,500 cells), and 28.5 llo f
RNAse free water (ﬁnal reaction volume 50 ll).
The PCR program used was the following: 2-min warm-up at 50 8C;
10-min denaturation at 95 8C; 45 cycles of 1-min annealing and
extension at 60 8C and 15-s denaturation at 95 8C; 20-sec annealing at
60 8C, and 20-min ramp up to 95 8C (for melting curve acquisition).
The reactions were performed in an ABI 7900HT (Applied
Biosystems, Foster City, California, United States).
No-template controls were always performed for each primer pair
and these PCR reactions were consistently negative for the presence
of amplicons. All reactions were run in duplicate and the mean
threshold cycle (CT) was calculated for each pair of reactions
performed for each of the two populations (CT
SP and CT
CD8). These
were normalized for beta-actin levels in each RNA sample (C’T
SP ¼
CT
SP –A T
SP and C’T
CD8¼CT
CD8 –A T
CD8, where AT is threshold cycle
for beta-actin in a particular sample). The log fold change for each
gene is given by LFCQPCR ¼ C’T
SP –C ’ T
CD8. Every selected gene was
tested in two independent RNA samples obtained from each
population. An average log fold change (Log QPCR) between the
two populations was obtained for each of the 22 genes studied.
A parallel value was calculated from the RMA data obtained from
ten-cell microarray experiments. The average expression levels for six
SP samples (performed in duplicate)a n dt h r e eC D 8s a m p l e s( i d e m )w e r e
calculated (E’
SP and E’
CD8). Since RMA expression levels are in a
logarithmic scale, the log fold change is given by LFCRMA¼E’
SP –E ’
CD8
(Log RMA). Corresponding log fold changes (Log QPCR and Log
RMA) for each gene were plotted in the same graph. A linear
regression model was ﬁtted to the values obtained.
Q-PCR validation for single-cell experiments. We sorted single
HSC into single wells of a 96-well plate containing 4 ll of the lysis
buffer used in our GSC RT-PCR reactions. We included both negative
and positive controls on each plate: wells containing only lysis buffer
(no cell) were used as negative controls, and wells containing lysis
buffer plus 25 stem cells were used as positive controls. A single gene
was analyzed per 96-well plate to minimize cross-contamination. Each
96-well plate was heated at 65 8C for 1 min and 25 8C for 2 min. We
performed reverse transcription reactions by adding 0.5 llo f
Superscript II reverse transcriptase (Invitrogen) followed by incuba-
tion of the plate at 42 8C for 60 min.
Following reverse transcription, cells were assayed for gene
expression using multiplexed Q-PCR, which simultaneously detected
18S rRNA and our gene-of-interest. Each reaction was performed by
mixing 25 ll TaqMan universal PCR master mix (Applied Biosystems),
2.5 ll of 18S rRNA endogenous control (VIC/MGB), 2.5 ll of gene-of-
interest TaqMan gene expression assay (FAM/MGB), and 16 llo f
nuclease-free water. The TaqMan gene expression assays (Applied
Biosystems) used included Mm00484032_g1 (Ctla2a),
Mm00493153_m1 (Lmo2), Mm00493153_m1 (Lyl1),
Mm00441665_m1 (Tal1), and Mm00445212_m1 (c-Kit). We utilized
the following cycling parameters: stage 1, 50 8C for 2 min; stage 2, 95
8C for 10 min; and stage 3, 94 8C for 15 s and 60 8C for 1 min. Stage 3
was repeated for a total of 60 cycles. A single cell Q-PCR was
considered successful when the CT for 18S was within the range of
26–30; the average 18S signal for all tested single cells was 28.5, while
the average 18S CT for negative control wells was 34. A gene was
considered to be expressed when it had a detectable signal within 60
cycles of ampliﬁcation. None of the negative control wells gave rise to
a positive signal for the genes studied.
Variance component analysis. We used maximum likelihood to
estimate the technical and biological contribution to the variance of
each gene with at least one P call in a single cell (6,675 genes) using all
17 data points from the single-cell and single-cell-equivalent data. We
assumed a Gaussian model for the expression measures and
considered the total variance for single cell experiments to be the
sum of independent technical and biological components, while for
t h es i n g l ec e l le q u i v a l e n td a t aw ea s s u m e do n l yat e c h n i c a l
component. We further supposed that the magnitude of the technical
variance was the same between the single cell and single cell
equivalent experiments. We used numerical methods to maximize
the log-likelihood function for each gene using the nlm procedure in
R (http://www.r-project.org) to directly maximize the function.
GO analysis. The GO analysis strategy used has been previously
described [16]. Brieﬂy, to assess the signiﬁcance of gene counts at
each GO category for a particular gene list, these were compared to
corresponding counts for the whole array. The probability of a count
of k genes in a GO node at some node of the G hierarchy was modeled
according to the hypergeometric probability law P(X¼k)¼B(C,k) B(L-
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Hematopoietic Stem Cell HeterogeneityC,n-k)/B(L,n), where B(x,y) stands for the binomial coefﬁcient for x
choose y. C is the total number of genes in the array annotated to the
GO node being considered, L is the number of genes in the array
annotated to all nodes, and n is the number of genes in a gene list
annotated to a GO term. The one-sided p-value for the node under
consideration is obtained by summing the probabilities obtained
from the formula for all X values from k to n. The GO signature for a
particular gene list is the subset of all GO categories represented in
that particular list which have an associated unadjusted p-value less
than 0.05.
Supporting Information
Figure S1. GSC RT-PCR Combined with Oligonucleotide Microarray
Analysis
Inourexperiments, oneora fewcells werelysedin a ﬁrststrandbuffer
and a short reverse transcription was performed (A), generating
limited-size cDNAs that represent the 39-most few-hundred nucleo-
tides of every mRNA molecule in solution. These products were then
polyadenylated (B) and ampliﬁed in a PCR reaction primed by an
oligonucleotide containing a poly-T tract (C–F). After random
digestion with DNase I into fragments averaging 50 bp, these targets
were end-labeled with biotinylated ddATP (G) and incubated with
Murine Genome U74A version 2 microarrays according to the
standard protocol (Affymetrix). For details, see Protocol S1.
Found at DOI: 10.1371/journal.pgen.0020159.sg001 (93 KB PDF).
Figure S2. The Transcriptional Representation Obtained by GSC RT-
PCR and DNase I Fragmentation of cDNA is Comparable between
Replicates
Three representative samples obtained from LSP (LA), USP (UN), and
CD8 cells (XB) are depicted. For each replicate pair, the expression
levels for each gene are plotted against each other (upper row).
Corresponding M-A plots are also shown (bottom row). The
distribution around a line with slope equal to one demonstrates that
the expression levels obtained are approximately the same. Each of
the replicate pairs used in our experiments has a correlation value
between 0.97 and 0.99.
Found at DOI: 10.1371/journal.pgen.0020159.sg002 (2.6 MB PDF).
Figure S3. Genetic Representation of Single-Cell Ampliﬁcations
The same list of genes used in Figure 4 was applied to generate the
heat map. Expression levels are normalized to 1 (white). Red genes are
over-expressed and blue genes under-expressed in that sample. Each
individual SCE sample is represented instead of the average of their
expression levels.
Found at DOI: 10.1371/journal.pgen.0020159.sg003 (97 KB PDF).
Figure S4. Position Analysis of High and Low Biological Variability
Genes in Single SP Cells
We performed a position analysis to compare high biological
variance and low biological variance results and identiﬁed 467 high
variance probe sets with present calls in at least four single cells and
more than 95% of total variance estimated to be biological and 361
probe sets with present calls in at least 12 samples and having less
than 5% of total variance estimated to be biological. The median
probe position for each probe set was normalized to the size of the
gene, with 1 representing the 39 end, and 0 the 59 end (horizontal
axis). Density is a measurement of the relative amount of probe sets
for each median position (vertical axis). A Wilcoxon signed rank test
shows no signiﬁcant difference in the median relative probe position
between the groups of probes sets.
Found at DOI: 10.1371/journal.pgen.0020159.sg004 (16 KB PDF).
Figure S5. Intensity Analysis of High and Low Biological Variability
Genes in Single SP Cells
The same gene sets used in Figure S4 were used for the analysis. The
relative amount of probe sets (density) is plotted against the
maximum expression level for a particular gene in the set of single
cells studied (as determined by the RMA algorithm). While genes with
high biological variance tend to have slightly lower maxima, the
distribution is similar between genes with high biological variance
and with low biological variance, with both groups having a similar
low intensity tail.
Found at DOI: 10.1371/journal.pgen.0020159.sg005 (15 KB PDF).
Protocol S1. Detailed Biological Methods
Found at DOI: 10.1371/journal.pgen.0020159.sd001 (64 KB DOC).
Table S1. Differentially Expressed Genes between SP Cells and CD8 T
Lymphocytes
Found at DOI: 10.1371/journal.pgen.0020159.st001 (608 KB XLS).
Table S2. List of Random Genes Selected for Q-PCR Validation
Found at DOI: 10.1371/journal.pgen.0020159.st002 (20 KB XLS).
Table S3. Differentially Expressed Genes between LSP Cells and USP
Cells
Found at DOI: 10.1371/journal.pgen.0020159.st003 (113 KB XLS).
Table S4. Variance Component Analysis for Genes with Four or More
‘‘Present’’ Calls in Single Cells
Found at DOI: 10.1371/journal.pgen.0020159.st004 (3.0 MB XLS).
Table S5. RMA Expression Levels in Each of the Samples Ampliﬁed
with GSC RT-PCR Followed by Oligonucleotide Microarray Analysis
Found at DOI: 10.1371/journal.pgen.0020159.st005 (9.2 MB XLS).
Table S6. MAS Calls in Each of the Samples Ampliﬁed with GSC RT-
PCR Followed by Oligonucleotide Microarray Analysis
Found at DOI: 10.1371/journal.pgen.0020159.st006 (7.9 MB XLS).
Table S7. GO Classiﬁcation Tables for High and Low Biological
Variance Genes
Found at DOI: 10.1371/journal.pgen.0020159.st007 (2.7 MB XLS).
Table S8. GO Signature Tables for High and Low Biological Variance
Genes
Found at DOI: 10.1371/journal.pgen.0020159.st008 (197 KB XLS).
Accession Numbers
The Entrez Gene (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼gene) accession numbers for the genes and gene products
discussed in this paper are Cd3g (12502), Cd3d (12500), Cd3e (12501),
Cd3z (12503), Zap70 (22637), Cd8a (12525), Cd8b1 (12526), Tal1/Scl-1
(21349), Ctla2b (13025), Abcb1b/Mdr1 (18669), Abcg2 (26357), Twsg1
(65960), Zfx (22764), E2f1 (13555), Ccna2 (12428), Hba-a1 (15122), Hbb
(15127), Hbb-b2 (15130), Cd14 (12475), Ly6c (17067), Ly6a/Sca-1
(110454), Lmo2 (16909), Ctla2a (116913), Mpl/TPO-R (17480), Flt3/Flk-
2 (14255), Cxcr4 (12767), Lyl1 (17095), Apex1 (11792), Ercc2 (13871), Lig1
(16881), Pttg1 (30939), Runx2 (12393), and Cbfb (12400).
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